ELISA results showed NETs from TBI patients, especially those with coagulopathy, could significantly impair endothelial dysfunction by decreasing the expression of syndecan-1, thrombomodulin, and VWF (Supplemental Figure 8, A–C). Here, THBD is linked to blood coagulation disease.